If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQG.L Regulatory News (IQG)

  • There is currently no data for IQG

Holding(s) in Company

2 Dec 2015 07:00

RNS Number : 6434H
Ubisense Group PLC
02 December 2015
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Ubisense Group PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Kestrel Partners LLP

4. Full name of shareholder(s)  (if different from 3.):iv

Kestrel Opportunities, a cell of Guernsey Portfolios PCC Ltd (through BNY Mellon Nominees Limited) and various other clients of Kestrel Partners LLP (through JIM Nominees Ltd and Bank of New York Nominees Ltd)

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

27 November 2015

6. Date on which issuer notified:

1 December 2015

7. Threshold(s) that is/are crossed orreached: vi, vii

22%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares of 2p each

ISIN GB00B3NCXX73

7,931,983

7,931,983

n/a

n/a

8,126,333

n/a

22.21%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

n/a

n/a

n/a

n/a

n/a

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

n/a

n/a

n/a

n/a

n/a

Nominal

Delta

n/a

n/a

Total (A+B+C)

Number of voting rights

Percentage of voting rights

8,126,333

22.21%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Indirect - BNY Mellon Nominees Limited - 5,985,835 Shares. 16.36% of voting rights

Indirect - JIM Nominees Limited - 641,435 Shares. 1.75% of voting rights

Indirect - Bank of New York (Nominees) Limited - 1,499,063 Shares. 4.10% of voting rights

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

Disclosure based on Total voting rights of 36,581,673The indirect voting rights held under (9) relate to shares held in client portfolios managed by Kestrel Partners LLP under discretionary investment management agreements

14. Contact name:

Ian Forrest

15. Contact telephone number:

0203 371 6100

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAXAFEENSFFF
Date   Source Headline
27th Mar 20177:00 amRNSDirectors' Dealings
22nd Mar 20177:00 amRNSDirectors' Dealings
21st Mar 20177:00 amRNSFinal Results
16th Mar 20177:00 amRNSNotice of Results
1st Mar 20172:39 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
27th Feb 20175:07 pmRNSTR-1: Notifications of Major Interests in Shares
8th Feb 20177:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
27th Jan 20177:00 amRNSTrading Statement
3rd Jan 20177:00 amRNSBlock listing Interim Review
15th Dec 20167:00 amRNSAppointment of CEO
15th Dec 20167:00 amRNSDirectors Dealings
25th Nov 20165:37 pmRNSDirectors' Dealings
8th Nov 20167:00 amRNSDirectors' Dealings
27th Oct 20164:18 pmRNSDirectors' Dealings
14th Sep 20167:00 amRNSDirector/PDMR Shareholding
16th Aug 20167:00 amRNSInterim Results
10th Aug 20167:00 amRNSAppointment of CFO
1st Jul 20167:00 amRNSTotal Voting Rights
22nd Jun 201611:02 amRNSResult of AGM
27th May 20167:00 amRNSNotice of AGM
18th May 20167:00 amRNSDirector resignation & appointment
28th Apr 201611:28 amRNSHolding(s) in Company
27th Apr 20162:58 pmRNSHolding(s) in Company
26th Apr 20165:48 pmRNSHolding(s) in Company
26th Apr 20168:00 amRNSDirector's Dealing
25th Apr 20163:18 pmRNSResult of General Meeting
7th Apr 201610:40 amRNS£4.8 million placing
7th Apr 201610:33 amRNSFinal Results
17th Mar 20167:00 amRNSNotice of Results
17th Mar 20167:00 amRNSNew contracts
9th Feb 20167:00 amRNSHolding(s) in Company
25th Jan 20167:00 amRNSTrading Statement
4th Jan 20167:00 amRNSBlocklisting Interim Review
4th Jan 20167:00 amRNSTotal Voting Rights
2nd Dec 20159:20 amRNSDirector/PDMR Shareholding
2nd Dec 20157:00 amRNSHolding(s) in Company
2nd Dec 20157:00 amRNSHolding(s) in Company
1st Dec 20157:00 amRNSTotal Voting Rights
27th Nov 20157:00 amRNSHolding(s) in Company
27th Nov 20157:00 amRNSHolding(s) in Company
23rd Nov 20157:00 amRNSHolding(s) in Company
12th Nov 20157:00 amRNSTrading Update
2nd Nov 20157:00 amRNSTotal Voting Rights
2nd Oct 20157:00 amRNSTotal Voting Rights
16th Sep 20157:00 amRNSHolding(s) in Company
2nd Sep 201511:45 amRNSTotal Voting Rights
1st Sep 20157:04 amRNSHolding(s) in Company
17th Aug 20157:00 amRNSInterim Results
8th Jul 20157:00 amRNSHolding(s) in Company
3rd Jul 20157:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.